Then, we performed ROC analysis to evaluate the diagnostic potency of ATF3 which demonstrated that ATF3 was a moderate predictor in liver cancer (AUC = 0.769, CI = 0.694–0.845) (Fig. 5D). Here, ATF3 is linked to liver cancer.